| Cat.No. | Name | Information |
|---|---|---|
| M1817 | Y-27632 dihydrochloride | Y-27632 is a potent, selective inhibitor of Rho-associated protein kinases (ROCK) with IC50 values of 140-220 nM for ROCK1 and ROCK2. In addition, Y-27632 inhibited LPA-induced entosis. |
| M5168 | GSK269962A | GSK269962A is a potent ROCK inhibitor with IC50 values of 1.6 and 4 nM for recombinant human ROCK1 and ROCK2, respectively. |
| M7388 | TC-S 7001 | TC-S 7001 is a potent and highly selective ROCK inhibitor; orally active. |
| M4938 | H-1152 | H-1152, an isoquinolinesulfonamide derivative, is a more specific, stronger and membrane-permeable inhibitor of Rho-kinase with a Ki value of 1.6 nM, but poor inhibitor of other serine/threonine kinases. |
| M49531 | Glycyl H-1152 hydrochloride | Glycyl H-1152 hydrochloride is a glycyl derivative of Rho-kinase inhibitors H-1152 dihydrochloride. |
| M49530 | Chroman 1 dihydrochloride | Chroman 1 dihydrochloride is a highly potent and selective ROCK inhibitor. |
| M49529 | CCG-232964 | CCG-232964 is an orally active inhibitor of Rho/MRTF/SRF. |
| M49527 | AR-13324 analog mesylate | AR-13324 analog mesylate is an analog of AR-13324. |
| M49526 | CAY10746 | CAY10746 is a selective Rho kinase (ROCK) inhibitor. |
| M49525 | 3-(4-Pyridyl)indole | 3-(4-Pyridyl)indole (Rockout) is a Rho-kinase (ROCK) inhibitor, with an IC50 of 25 μM. |
| M41597 | ROCK-IN-9 | ROCK-IN-9 is a ROCK inhibitor. |
| M41596 | ROCK-IN-7 | ROCK-IN-7 is a ROCK kinase inhibitor. |
| M41595 | ROCK-IN-8 | ROCK-IN-8 is a ROCK inhibitor, with an IC50 value less than 100 nM. |
| M41594 | CaMKP inhibitor sodium | CaMKP inhibitor sodium is a selective inhibitor of ROCK1 with an IC50 value of 14 nM. |
| M41593 | Rho-Kinase-IN-3 | Rho-Kinase-IN-3 is a potent and selective Rho kinase (ROCK1) inhibitor with an IC50 value of 8 nM. |
| M41592 | THK01 | THK01 is a potent ROCK2 inhibitor with IC50 values of 5.7 and 923 nM for ROCK2 and ROCK1, respectively. |
| M41591 | ROCK2-IN-6 | ROCK2-IN-6 is a selective ROCK2 inhibitor, can be used for ROCK mediated diseases, autoimmune diseases and inflammation research. |
| M41590 | ROCK2-IN-6 hydrochloride | ROCK2-IN-6 hydrochloride is a selective ROCK2 inhibitor, can be used for ROCK mediated diseases, autoimmune diseases and inflammation research. |
| M40627 | BA-1076 | BA-1076 is a ROCK1/2 inhibitor that can be used in glaucoma-related studies. |
| M40626 | AR-13503 | AR-13503 is an active metabolite of Netarsudil and a PKC/ROCK inhibitor that inhibits angiogenesis and enhances retinal pigment epithelium (RPE) permeability. It can be used in studies related to diabetic macular edema and macular degeneration. |
| M40625 | Zelasudil | Zelasudil (RXC-007) is a selective ROCK2 inhibitor for studies related to idiopathic pulmonary fibrosis. |
| M40624 | OPL-0401 | OPL-0401 is an orally active small molecule Rho-kinase (ROCK 1/2) inhibitor for studies related to non-proliferative diabetic retinopathy. |
| M40623 | Fasudil mesylate | Fasudil mesylate is a potent inhibitor of ROCKs with neuroprotective activity for studies related to cerebral infarction. |
| M31008 | Sovesudil hydrochloride | Sovesudil (PHP-201) hydrochloride is a potent, ATP-competitive, locally acting Rho kinase (ROCK) inhibitor with IC50s of 3.7 and 2.3 nM for ROCK-I and ROCK-II, respectively. Sovesudil hydrochloride lowers intraocular pressure (IOP) without inducing hyperemia. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
